Neoantigens are somatically mutated protein sequences presented on MHC Class I or II molecules. Mounting evidence suggests neoantigens potentiate anti-tumor immune responses during checkpoint blockade, and there is great interest in directly targeted neoantigens therapeutically with vaccine. Such vaccines must rely on personalized in silico epitope prediction given the multitude of MHC alleles in the human population (each with its own peptide binding repertoire) and the very small degree of somatic mutation overlap amongst cancer patients. The current prediction paradigm is based almost entirely on machine learning algorithms (e.g. NetMHC) trained on in vitro p:MHC binding affinity assays.
Here we modify the MS approach to focus on an MHC-null cell line transfected with a single allele of our choice. We iteratively applied rapid, high-resolution liquid chromatography mass spectrometry (LC-MS/MS) to 16 HLA alleles identifying >24,000 MHC-bound peptides. Using these data, we were able to learn peptide-binding and proteasomal cleavage motifs de novo. In addition, we uncovered new motifs absent in the public database IEDB (which would have been impossible using the multi-allelic MS approach) and validated these with traditional in vitro binding assays. Furthermore, we systematically assess variables hypothesized to predict presentation. Notably, we find that transcript expression is highly predictive of presentation and that source protein localization makes minimal incremental contribution.
Finally, we trained neural network models on our endogenous peptide dataset to produce integrated predictors that leverage both peptide sequence and auxiliary variables such as gene expression and the likelihood of efficient proteasomal processing. We demonstrate effective prediction in MS data sets collected by independent groups, achieving 2-3x more correct identifications than NetMHC or NetMHCPan. We also show compelling performance in predicting immunogenic HIV epitopes. We conclude that measuring mono-allelic MHC peptides using LC-MS/MS improves the utility of predictive algorithms and provides a rapid and scalable method to generate rules for neoantigen prediction.
Single-allele system identifies novel motifs that are not discoverable using traditional multi-allelic approach
Conclusions and Next Steps
• Single-allele system generates high coverage and enables deep integrative analysis by removing the problem of allele ambiguity
• MS data can be used to learn peptide motifs and cleavage motifs de novo and to systematically probe how various factors (protein localization, expression, etc.) impact epitope presentation
• These findings will yield new predictors that will be critical to the success of personalized neoantigen approaches Single-allele data enables development of data-driven integrated predictors; expression and cleavability greatly increase accuracy
• Logistic regression models were developed to discriminate n MS-observed peptides from 999n genomic 9mer decoys • Each model included a different subset of predictors, e.g. IsBinder~ β 0 + β 1 NetMHCScore + β 2 Expression • Model performance was assessed according to the fraction of true MS peptides among the most highly ranked peptides (top 0.1%); this score is called the positive predictive value (PPV)
Positive predictive value (PPV) of model using given subset of predictor variables
Stepwise addition of variables reveals the following explanatory contributions (averaged across all alleles)
Novel predictors based on our single-allele MS data outperform NetMHC on external test data
• Bassani-Sternberg et al (2015) identified MHC-bound peptides for six human cell lines using mass spectrometry • We evaluated our algorithms by seeing whether we could distinguish these peptides from decoys (999 decoys per true peptide)
• Our MS-based predictor bests NetMHC for almost every allele we could evaluate • Adding expression and cleavage to the model ("+ EC") improves prediction further -2-3x the performance of NetMHC
• The Los Alamos 2013 HIV-1 CTL Epitope Update lists 52 HIV-1 epitopes associated with alleles included in our study • We used our predictor to rank these relative to the remaining 9mers in the HIV-1 genome • The MS predictor was almost always able to nominate true epitopes to higher rank than NetMHC-4.0 or NetMHCPan-2.8
Michael S. Below:
• The upstream and downstream sequence of each MS binder was compared to decoy sequences • Heatmap shows percent change in frequency of given amino acid at given position when comparing binders to decoys • Signature is preserved in breast, colorectal, and fibroblast cell lines as well as HeLa and PBMC.
Not controlling for expression level

Controlling for expression level
The count of known ubiquitination sites in the source protein is associated with enhanced peptide presentation Most cellular localization bias can be explained by expression 
